MentionFox
Home › Stakes › Tarsus Pharmaceuticals, Inc.
5%+ stakes · Schedule 13D and 13G

Tarsus Pharmaceuticals, Inc.: 5%+ holders

Who has reported owning 5% or more of Tarsus Pharmaceuticals, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more3
Filings10
Latest filing2026-08-13

Tarsus Pharmaceuticals, Inc. has 10 Schedule 13D or 13G filings on record since 2025-07-28. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Deep Track Capital, LP8.46%3,600,000SCHEDULE 13G/A, 2026-05-152026-03-31
RTW Investments, LP8.1%3,424,180SCHEDULE 13G/A, 2025-08-142025-06-30
JANUS HENDERSON GROUP Ltd.6.5%2,808,796SCHEDULE 13G/A, 2026-08-132026-06-30
Prudential Financial Inc4.3%1,836,321SCHEDULE 13G/A, 2026-05-082026-03-31
Jennison Associates LLC4%1,712,124SCHEDULE 13G/A, 2026-05-062026-03-31
Tang Capital Management, LLC2.8%1,188,624SCHEDULE 13G/A, 2026-02-172025-12-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13

Timeline

FiledHolderPercentFiling
2025-07-28Deep Track Capital, LP5.6%SCHEDULE 13G
2025-08-14RTW Investments, LP8.1%SCHEDULE 13G/A
2025-11-14Deep Track Capital, LP7.11%SCHEDULE 13G/A
2026-02-17Tang Capital Management, LLC2.8%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-05-06Jennison Associates LLC4%SCHEDULE 13G/A
2026-05-08Prudential Financial Inc4.3%SCHEDULE 13G/A
2026-05-15Deep Track Capital, LP8.46%SCHEDULE 13G/A
2026-05-15Janus Henderson Group Plc5.3%SCHEDULE 13G
2026-08-13JANUS HENDERSON GROUP Ltd.6.5%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for Tarsus Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/tarsus-pharmaceuticals
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Tarsus Pharmaceuticals, Inc. 5%+ holders: 3 at 5% or more, largest Deep Track Capital, LP 8.46%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/tarsus-pharmaceuticals